pain
Conditions
Interventions
The experiment group :The experiment group received 1 mg·kg-1·d-1 esketamine +1 µg/·kg-1·d-1 sufentanil for intravenous postoperative analgesia
Control group:The control group received 1 µg/·kg-1·d-1 sufentanil for intravenous analgesia.
Sponsors
Women and Children’s Hospital of Jiaxing
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Mothers with ASA grades 1-2, age 20-35, height 155-175 cm, gestational age 37-41 weeks, and weight 55-85 kg
Exclusion criteria
Exclusion criteria: Patients with pregnancy complicated by hypertension, neurological disorders, abnormal coagulation function, placental implantation, and placenta previa
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea and vomiting; | — |
Countries
China
Contacts
Public ContactZhao Yanping
Women and Children’s Hospital of Jiaxing
Outcome results
None listed